Afynia Laboratories Inc. is thrilled to announce a significant funding achievement that sets the stage for transformative advancements in women鈥檚 health. The pre-clinical FemTech company, co-founded by visionary scientists dedicated to research in reproductive endocrinology and infertility, has successfully secured $5 million in funding to drive the development of innovative health solutions. This critical investment will enable Afynia Laboratories to accelerate the creation of its flagship product鈥攁 game-changing solution designed to provide clarity and relief for individuals grappling with chronic pelvic pain, menstrual pain, or infertility linked to endometriosis. By addressing a pressing need in a market that often overlooks women's specific health challenges, Afynia aims to develop products that not only fill existing gaps but also empower women with knowledge and peace of mind. The funding will bolster research and development efforts, enhance clinical trials, and expand outreach initiatives aimed at raising awareness about endometriosis and related conditions. With this financial boost, Afynia Laboratories is poised to make a significant impact on women's health and aims to position itself as an international leader in the marketplace. As the company works toward its mission, it invites the community to join them on this journey toward improving the lives of millions. For more information on this groundbreaking work, please reach out to us at info@afynia.com.
Breaking News: Afynia Labs Raises Pre-Seed Funding to Revolutionize Women's Health Tech
Recently funded 路 Pre-seedHealthcare
Get the full Afynia Laboratories company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Pre-seed rounds
Companies that recently closed a Pre-seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Dognosis India | Pre-seed | $1.5M | today |
| 2 | Dognosis India | Pre-seed | $1.5M | today |
